Hybrigenics SA logo

ALHYG - Hybrigenics SA Share Price

€0.184 0.0  11.5%

Last Trade - 03/07/20

Sector
Healthcare
Size
Micro Cap
Market Cap £6.95m
Enterprise Value £6.39m
Revenue £47.8k
Position in Universe 780th / 854
Bullish
Bearish
Unlock ALHYG Revenue
Momentum
Relative Strength (%)
1m -6.57%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -78.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2012 2013 2014 2015 2016 2017 2018E 2019E CAGR / Avg
4.09 4.98 5.27 1.16 1.49 0.000 3.57 2.17 -100.0%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2019, Hybrigenics SA revenues decreased 96% to EUR2K. Net loss applicable to common stockholders decreased 88% to EUR381K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Other Purchases & External Charges decrease of 87% to EUR392K (expense), Exc Inc/Other Exc Income increase from EUR103K to EUR808K (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ALHYG Revenue Unlock ALHYG Revenue

Net Income

ALHYG Net Income Unlock ALHYG Revenue

Normalised EPS

ALHYG Normalised EPS Unlock ALHYG Revenue

PE Ratio Range

ALHYG PE Ratio Range Unlock ALHYG Revenue

Dividend Yield Range

ALHYG Dividend Yield Range Unlock ALHYG Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ALHYG EPS Forecasts Unlock ALHYG Revenue
Profile Summary

Hybrigenics SA is France-based Company engaged in the biotechnological sector. It specializes in the research and development of drugs intended for cancer treatment and supplies scientific services in the protein interaction field. The Company is specialized in the research and development (R&D) of drugs to fight cancer. It is organized in two units: Hybrigenics Pharma for internal R&D, which develops a research program aimed at such diseases as melanoma and prostate cancer; and Hybrigenics Services for commercial business, mainly engaged in protein interaction information and solutions. Hybrigenics SA’s main development program is based on inecalcitol, a vitamin D analogue, for prostate cancer treatment. It operates through Hybrigenics Corporation and Imaxio.

Directors
Last Annual December 31st, 2017
Last Interim June 30th, 2019
Incorporated January 1, 1998
Public Since December 17, 2007
No. of Shareholders: n/a
No. of Employees: 17
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Euronext - Paris
Shares in Issue 46,753,948
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ALHYG Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ALHYG
Upcoming Events for ALHYG
Friday 18th September, 2020 Estimate
Hybrigenics SA Annual Shareholders Meeting
Frequently Asked Questions for Hybrigenics SA
What is the Hybrigenics SA share price?

As of 03/07/20, shares in Hybrigenics SA are trading at €0.184, giving the company a market capitalisation of £6.95m. This share price information is delayed by 15 minutes.

How has the Hybrigenics SA share price performed this year?

Shares in Hybrigenics SA are currently trading at €0.184 and the price has moved by 49.73% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Hybrigenics SA price has moved by 64.4% over the past year.

What are the analyst and broker recommendations for Hybrigenics SA?

Of the analysts with advisory recommendations for Hybrigenics SA, there are there are currently 0 "buy" , 0 "hold" and 1 "sell" recommendations. The overall consensus recommendation for Hybrigenics SA is Strong Sell. You can view the full broker recommendation list by unlocking its StockReport.

When will Hybrigenics SA next release its financial results?

Hybrigenics SA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-06-30
What is the Hybrigenics SA dividend yield?

Hybrigenics SA does not currently pay a dividend.

Does Hybrigenics SA pay a dividend?

Hybrigenics SA does not currently pay a dividend.

When does Hybrigenics SA next pay dividends?

Hybrigenics SA does not currently pay a dividend.

How do I buy Hybrigenics SA shares?

To buy shares in Hybrigenics SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Hybrigenics SA?

Shares in Hybrigenics SA are currently trading at €0.184, giving the company a market capitalisation of £6.95m.

Where are Hybrigenics SA shares listed? Where are Hybrigenics SA shares listed?

Here are the trading details for Hybrigenics SA:

Country of listing: France
Exchange: PAR
Ticker Symbol: ALHYG
What kind of share is Hybrigenics SA?

Based on an overall assessment of its quality, value and momentum, Hybrigenics SA is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Hybrigenics SA share price forecast 2020?

Shares in Hybrigenics SA are currently priced at €0.184. At that level they are trading at 0.306% discount to the analyst consensus target price of 0.00.

Analysts covering Hybrigenics SA currently have a consensus Earnings Per Share (EPS) forecast of -0.087 for the next financial year.

How can I tell whether the Hybrigenics SA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hybrigenics SA. Over the past six months, the relative strength of its shares against the market has been 98.84%. At the current price of €0.184, shares in Hybrigenics SA are trading at 26.89% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Hybrigenics SA PE Ratio?

We were not able to find PE ratio data for Hybrigenics SA.

Who are the key directors of Hybrigenics SA?

Hybrigenics SA's management team is headed by:

Remi Delansorne - CEO
Jean-Francois Dufour-Lamartinie - VRD
Piet Serrure - DRC
Guillaume Floch - CFO
Etienne Formstecher - CEX
Alain Munoz - CHM
Albert Saporta - IND
Who are the major shareholders of Hybrigenics SA?

Here are the top five shareholders of Hybrigenics SA based on the size of their shareholding:

Diagnostic Medical Systems SA Corporation
Percentage owned: 80% (187.0m shares)
Similar to ALHYG
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.